Roger Song
Stock Analyst at Jefferies
(1.86)
# 3,142
Out of 4,944 analysts
48
Total ratings
38.46%
Success rate
-9.17%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Roger Song
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LVTX LAVA Therapeutics | Downgrades: Hold | $3 → $1.5 | $1.53 | -1.96% | 1 | Aug 5, 2025 | |
| KNSA Kiniksa Pharmaceuticals International, | Maintains: Buy | $45 → $54 | $33.65 | +60.48% | 3 | Jul 29, 2025 | |
| REPL Replimune Group | Maintains: Buy | $31 → $6 | $5.09 | +17.88% | 2 | Jul 22, 2025 | |
| CVAC CureVac | Downgrades: Hold | $7 → $5 | $5.50 | -9.09% | 1 | Jun 13, 2025 | |
| NKTR Nektar Therapeutics | Upgrades: Buy | $15 → $30 | $25.72 | +16.64% | 11 | Apr 11, 2025 | |
| AKBA Akebia Therapeutics | Initiates: Buy | $6 | $3.30 | +81.82% | 1 | Apr 1, 2025 | |
| SANA Sana Biotechnology | Initiates: Buy | $7 | $3.33 | +110.21% | 1 | Mar 14, 2025 | |
| KRYS Krystal Biotech | Initiates: Buy | $245 | $149.36 | +64.03% | 1 | Mar 5, 2025 | |
| WVE Wave Life Sciences | Initiates: Buy | $26 | $8.76 | +196.80% | 1 | Feb 25, 2025 | |
| IGMS IGM Biosciences | Downgrades: Hold | $48 → $2 | $1.27 | +57.48% | 2 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $42 → $7 | $4.57 | +53.17% | 2 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $28 | $6.49 | +331.43% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $2 → $7 | $1.70 | +311.76% | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $89 | $61.10 | +45.66% | 1 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $25 | $8.85 | +182.49% | 2 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $41 | $10.57 | +287.89% | 1 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $16.75 | +108.96% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $5.15 | +74.76% | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $129 | $31.55 | +308.87% | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $2.5 → $8 | $1.78 | +350.70% | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $97 | $78.24 | +23.98% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $72 | $22.22 | +224.03% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $110 | $41.27 | +166.54% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $35 | $3.74 | +835.83% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $0.91 | +893.38% | 1 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $5.00 | +60.00% | 2 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $0.77 | +2,620.21% | 1 | Sep 2, 2020 |
LAVA Therapeutics
Aug 5, 2025
Downgrades: Hold
Price Target: $3 → $1.5
Current: $1.53
Upside: -1.96%
Kiniksa Pharmaceuticals International,
Jul 29, 2025
Maintains: Buy
Price Target: $45 → $54
Current: $33.65
Upside: +60.48%
Replimune Group
Jul 22, 2025
Maintains: Buy
Price Target: $31 → $6
Current: $5.09
Upside: +17.88%
CureVac
Jun 13, 2025
Downgrades: Hold
Price Target: $7 → $5
Current: $5.50
Upside: -9.09%
Nektar Therapeutics
Apr 11, 2025
Upgrades: Buy
Price Target: $15 → $30
Current: $25.72
Upside: +16.64%
Akebia Therapeutics
Apr 1, 2025
Initiates: Buy
Price Target: $6
Current: $3.30
Upside: +81.82%
Sana Biotechnology
Mar 14, 2025
Initiates: Buy
Price Target: $7
Current: $3.33
Upside: +110.21%
Krystal Biotech
Mar 5, 2025
Initiates: Buy
Price Target: $245
Current: $149.36
Upside: +64.03%
Wave Life Sciences
Feb 25, 2025
Initiates: Buy
Price Target: $26
Current: $8.76
Upside: +196.80%
IGM Biosciences
Jan 10, 2025
Downgrades: Hold
Price Target: $48 → $2
Current: $1.27
Upside: +57.48%
Dec 9, 2024
Downgrades: Hold
Price Target: $42 → $7
Current: $4.57
Upside: +53.17%
Nov 21, 2024
Maintains: Buy
Price Target: $32 → $28
Current: $6.49
Upside: +331.43%
Nov 19, 2024
Upgrades: Buy
Price Target: $2 → $7
Current: $1.70
Upside: +311.76%
Oct 23, 2024
Initiates: Buy
Price Target: $89
Current: $61.10
Upside: +45.66%
Oct 16, 2024
Maintains: Buy
Price Target: $31 → $25
Current: $8.85
Upside: +182.49%
Oct 11, 2024
Initiates: Buy
Price Target: $41
Current: $10.57
Upside: +287.89%
Oct 8, 2024
Initiates: Buy
Price Target: $35
Current: $16.75
Upside: +108.96%
Sep 5, 2024
Initiates: Buy
Price Target: $9
Current: $5.15
Upside: +74.76%
Sep 3, 2024
Maintains: Buy
Price Target: $108 → $129
Current: $31.55
Upside: +308.87%
May 6, 2024
Upgrades: Buy
Price Target: $2.5 → $8
Current: $1.78
Upside: +350.70%
Apr 17, 2024
Initiates: Buy
Price Target: $97
Current: $78.24
Upside: +23.98%
Mar 20, 2024
Maintains: Buy
Price Target: $41 → $72
Current: $22.22
Upside: +224.03%
Mar 7, 2024
Initiates: Buy
Price Target: $110
Current: $41.27
Upside: +166.54%
Aug 31, 2022
Maintains: Buy
Price Target: $30 → $35
Current: $3.74
Upside: +835.83%
Jul 29, 2022
Initiates: Buy
Price Target: $9
Current: $0.91
Upside: +893.38%
Dec 1, 2021
Initiates: Buy
Price Target: $8
Current: $5.00
Upside: +60.00%
Sep 2, 2020
Initiates: Buy
Price Target: $21
Current: $0.77
Upside: +2,620.21%